DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides

Abstract

The present invention provides luminescent complexes between a lanthanide ion and an organic ligand which contains 1,2-hydroxypyridinone units. The complexes of the invention are stable in aqueous solutions and are useful as molecular probes, for example in medical diagnostics and bioanalytical assay systems. The invention also provides methods of using the complexes of the invention.

Inventors:
; ; ;
Issue Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1176518
Patent Number(s):
8557601
Application Number:
12/373,275
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Classifications (CPCs):
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07D - HETEROCYCLIC COMPOUNDS
C - CHEMISTRY C09 - DYES C09K - MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
DOE Contract Number:  
AC03-76SF00098
Resource Type:
Patent
Resource Relation:
Patent File Date: 2007 Jul 10
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY

Citation Formats

Raymond, Kenneth N., Xu, Jide, Moore, Evan G., and Werner, Eric J. Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides. United States: N. p., 2013. Web.
Raymond, Kenneth N., Xu, Jide, Moore, Evan G., & Werner, Eric J. Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides. United States.
Raymond, Kenneth N., Xu, Jide, Moore, Evan G., and Werner, Eric J. Tue . "Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides". United States. https://www.osti.gov/servlets/purl/1176518.
@article{osti_1176518,
title = {Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides},
author = {Raymond, Kenneth N. and Xu, Jide and Moore, Evan G. and Werner, Eric J.},
abstractNote = {The present invention provides luminescent complexes between a lanthanide ion and an organic ligand which contains 1,2-hydroxypyridinone units. The complexes of the invention are stable in aqueous solutions and are useful as molecular probes, for example in medical diagnostics and bioanalytical assay systems. The invention also provides methods of using the complexes of the invention.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Oct 15 00:00:00 EDT 2013},
month = {Tue Oct 15 00:00:00 EDT 2013}
}

Works referenced in this record:

Gadolinium(III) 1,2-Hydroxypyridonate-Based Complexes: Toward MRI Contrast Agents of High Relaxivity1
journal, September 2004


3-hydroxy-2(1H)-pyridinone chelating agents
patent, April 1999


Syntheses and Relaxation Properties of Mixed Gadolinium Hydroxypyridinonate MRI Contrast Agents
journal, December 2000


In Vivo Chelation of Am(III), Pu(IV), Np(V), and U(VI) in Mice by TREN-(Me-3,2-HOPO)
journal, May 1994


Polymeric membranes functionalized with polyhydroxypyridinone ligands
patent, April 2001


Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligands
journal, January 1988


Salicylamide-lanthanide complexes for use as luminescent markers
patent, June 2002


Time-resolved fluorometry: a sensitive method to quantify DNA-hybrids
journal, January 1986


Phthalamide-lanthanide complexes for use as luminescent markers
patent-application, September 2002


Force Field Parametrization for Gadolinium Complexes Based on ab Initio Potential Energy Surface Calculations
journal, April 2000


Highly Soluble Tris-hydroxypyridonate Gd(III) Complexes with Increased Hydration Number, Fast Water Exchange, Slow Electronic Relaxation, and High Relaxivity1
journal, February 2007


In vitro removal of actinide (IV) ions
patent, January 1982


Stereospecific binding of MRI contrast agents to human serum albumin: the case of Gd-(S)-EOB-DTPA (Eovist) and its (R) isomer
journal, February 2001


6-Carboxamido-5,4-Hydroxypyrimidinones: A New Class of Heterocyclic Ligands and Their Evaluation as Gadolinium Chelating Agents
journal, December 2001


In vivo diagnosis and therapy of human tumors with monoclonal antibodies: Overview of the symposium
journal, January 1989


Study of metal complexes of a tripodal hydroxypyridinone ligand by electrospray tandem mass spectrometry
journal, June 2005

  • Budimir, Natali; Fournier, Françoise; Bailly, Théodorine
  • Rapid Communications in Mass Spectrometry, Vol. 19, Issue 13, p. 1822-1828
  • https://doi.org/10.1002/rcm.1993

Synthesis of 3,4,3 LI 1,2 HOPO labelled with 14C: Synthesis of 3,4,3
journal, February 2001


Imaging agents for in vivo magnetic resonance and scintigraphic imaging
patent, April 1991


Next Generation, High Relaxivity Gadolinium MRI Agents
journal, December 2004


3-hydroxy-2(1H)-pyridinone chelating agents
patent, April 1997


Selective Inhibition of Fe-versus Cu/Zn-Superoxide Dismutases by 2,3-Dihydroxybenzoic Acid Derivatives
journal, January 2002


Hydroxypyridonate and hydroxypyrimidinone chelating agents
patent, May 2010


Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties and biological activity
journal, June 1990


Phthalamide-lanthanide complexes for use as luminescent markers
patent, March 2005


Phthalamide lanthanide complexes for use as luminescent markers
patent, February 2003


Hydroxypyridonate and hydroxypyrimidinone chelating agents
patent, January 2005


Polycatecholamide chelating agents
patent, April 1984


A solid-state study of eight-coordinate lanthanide(iii) complexes (Ln = Eu, Gd, Tb, Dy) with 1-hydroxy-2-pyridinone
journal, March 2003


Gadolinium complex of tris[(3-hydroxy-1-methyl- 2-oxo-1,2-didehydropyridine-4-carboxamido)ethyl]-amine: A New Class of gadolinium magnetic resonance relaxation agents
journal, July 1995


2,3-dihydroxyterephthalamides as highly effective metal ion sequestering compounds
patent, September 1991


Pharmaceutical compositions of hydroxypyridones
patent, May 1987


Rational reduction of the conformational space of a siderophore analog through nonbonded interactions: the role of entropy in enterobactin
journal, July 1993


Gadolinium-containing copolymeric chelates—a new potential MR contrast agent
journal, August 1999


Template synthesis of macrocyclic catecholamide complexes
patent, July 1990


Oxygen‐17 NMR and EPR studies of water exchange from the first coordination sphere of gadolinium(III) aquoion and gadolinium(III) propylenediaminetetra‐acetate
journal, December 1980

  • Southwood‐Jones, Rosalind V.; Earl, William L.; Newman, Kenneth E.
  • The Journal of Chemical Physics, Vol. 73, Issue 12, p. 5909-5918
  • https://doi.org/10.1063/1.440148

Ferric ion sequestering agents. 14. 1-Hydroxy-2(1H)-pyridinone complexes: properties and structure of a novel iron-iron dimer
journal, November 1985


Detection of pulmonary emboli by using MR angiography with MPEG-PL-GdDTPA: an experimental study in rabbits.
journal, May 1994


Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands
journal, February 1993


Hydroxypyridonate and hydroxypyrimidinone chelating agents
patent-application, January 2005


Hydroxypyridonate chelating agents
patent, October 1987


Stereoselectivity in chiral iron(III) and gallium(III) tris(catecholate) complexes effected by nonbonded weakly polar interactions
journal, July 1993


Nouvelle méthode de synthèse du 3,4,3 LI 1,2 HOPO (1,5,10,14-tétra (1-hydroxy-2-pyridone-6 oyl) 1,5,10,14 tétraazatétradécane) [A new synthesis of 3,4,3 LI 1,2 HOPO]
journal, April 1998


Synthesis of a Ligand Based upon a New Entry into the 3-Hydroxy-N-alkyl-2(1H)-pyridinone Ring System and Thermodynamic Evaluation of Its Gadolinium Complex
journal, June 2000


Tris(pyrone) Chelates of Gd(III) as High Solubility MRI-CA
journal, February 2006


2,3-Dihydroxybenzoic acid amides of tetraazaalkanes and tetaaza cycloalkanes
patent, January 1980


A Tris-hydroxymethyl-Substituted Derivative of Gd-TREN-Me-3,2-HOPO: An MRI Relaxation Agent with Improved Efficiency
journal, November 2000